Breast Cancer News
In this section, access cutting-edge metastatic breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
ZURICH (Reuters) - European healthcare regulators are reviewing the benefits of Roche's top-selling Avastin drug in breast cancer in the light of fresh clinical data, casting more uncertainty over its prospects.
Lapatinib plus Trastuzumab was more effective than Lapatinib alone for women with HER2 positive advanced breast cancer that progressed on trastuzumab, San Antonio study shows.
Four studies presented at the San Antonio Breast Cancer Symposium looked at existing therapies being tested in unique ways as the landscape of acceptable treatment and management of breast cancer continues to shift.
Single-agent chemotherapy is recommended over combination for metastatic disease, says the European School of Oncology’s Metastatic Breast Cancer Task Force.
We encourage you to join the efforts of our friends at the Metastatic Breast Cancer Network to declare October 13 National Metastatic Breast Cancer Awareness Day.
Olaparib, a PARP inhibitor pill, worked powerfully against BRCA-related metastatic breast cancers, an American Society of Clinical Oncology (ASCO) study showed.
PARP inhibitors, added to chemotherapy, show promise in treating metastatic triple-negative breast cancer.
Low-dose estradiol worked as well as high-dose but had fewer side effects for postmenopausal women with hormone-sensitive metastatic breast cancer resistant to aromatase inhibitor therapy.